Lung cancer screening promises to find cancer early and treat it before it progresses. But a year on, issues have emerged.
Articles on Lung cancer
Displaying 1 - 20 of 85 articles
Workers are facing a preventable and incurable lung disease from a material being used to renovate kitchens in millions of American homes.
A small conference study sparked headlines linking fruit to lung cancer. Here’s why the science tells a very different story.
The blaze at the Geelong oil refinery in Victoria has reportedly been extinguished. But residents in the area may be worried about the health effects of lingering smoke.
The evidence shows nicotine-based vapes are likely to cause oral and lung cancer. We just don’t yet know how many cases it will cause.
Only 50% of Colorado homes have been tested for radon.
Australia’s new lung cancer screen program further disadvantages Aboriginal and Torres Strait Islander peoples, who are already at increased risk of lung cancer.
The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.
The aim is to find and treat lung cancers early, before they grow and spread, to improve the chance of survival. Here’s what’s involved.
Silicosis is a serious, incurable lung disease caused by inhaling small particles of silica dust.
Rising air pollution, changes in hormone levels, immune system imbalances and longer life expectancy are increasing the risk of lung cancer in women who have never touched a cigarette.
Research shows regular physical activity can significantly improve quality of life for lung cancer patients. This includes less fatigue, less breathlessness, and better sleep.
Half of all GP practices in New Zealand have closed their books to new patients. This means people are going on emergency departments for care – with deadly outcomes when it comes to lung cancer.
Green algae carry drug-loaded nanoparticles directly to the lungs, reducing side effects in other organs and increasing treatment efficiency.
Stigma, fear and cost prevent many patients from getting screened for lung cancer. This can prove deadly for the most vulnerable.
Reducing particle pollution can save thousands of lives, but states need more data to inform better controls. An atmospheric scientist explains what data and actions are needed.
Treatment for lung cancer patients is the same for everyone, regardless of the risk of recurrence. The use of a new technology could refine diagnosis.
Tobacco harms the very structure of our cells, and affects almost every part of our bodies and nervous systems.
On Feb. 7, 2024, the EPA strengthened the federal limit for annual levels of fine particulate air pollution, or PM2.5. Many serious health effects have been linked to PM2.5 exposure.
Engineered stone is a popular material often used for kitchen benches. But it carries serious health risks for the tradies who work with it.
Top contributors
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, Adelaide University
-
Senior Research Fellow, School of Population Health, Curtin University
-
Emeritus Professor in Public Health, University of Sydney
-
Chancellor's Professor of Medicine, Liberal Arts, and Philanthropy, Indiana University
-
Professor of Medicine, University of California, San Francisco
-
Professor of Epidemiology, Curtin University
-
Adjunct Senior Lecturer, Centre for Primary Health Care and Equity, University of New South Wales, UNSW
-
Professor at University of Melbourne and Research Fellow, Cancer Council Victoria
-
Adjunct Professor, School of Psychology, Curtin University and College of Health and Medicine, Australian National University
-
Professor of Sociology & Director, Sydney Centre for Healthy Societies, University of Sydney
-
Professor and Dean, School of Public Health, Georgia State University
-
Professor in Molecular and Clinical Cancer Medicine, University of Liverpool
-
Professor and NHMRC Australian Fellow, Medicine, University of Sydney
-
Professor, Department of Hematology and Medical Oncology, Emory University
-
Professor and Director of the National Drug and Alcohol Research Centre, UNSW